{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:29:23Z","timestamp":1776832163577,"version":"3.51.2"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The association between a preceding malignancy and the onset of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has been reported in several studies. While the co-existence of ANCA and anti-glomerular basement membrane (GBM) antibodies in an individual patient is not a common occurrence, this double-positive disease currently has no optimal treatment method. Herein, we report a case of a double-positive disease involving the sequential development of acute kidney injury (AKI) and diffuse alveolar hemorrhage (DAH) in a patient with small cell lung cancer (SCLC).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 75-year-old Japanese woman was diagnosed with small cell lung cancer (cT3N2M1b cStage IV) and received chemotherapy. After one cycle of chemotherapy, she experienced fever and malaise. Her serum creatinine level rapidly increased, and she tested positive for myeloperoxidase (MPO)-ANCA and anti-GBM antibody. She was diagnosed with AKI due to microscopic polyangiitis (MPA) based on renal biopsy. Corticosteroid therapy was initiated, which improved her renal dysfunction. Eight days after she was discharged from the hospital, she complained of dyspnea and bloody sputum, and her condition rapidly progressed to\u00a0respiratory failure. Upon chest imaging, ground-glass opacities were seen in her bilateral lower lungs. Laboratory examinations after admission revealed a lower MPO-ANCA titer and an elevated anti-GBM antibody titer compared to her previous admission. We diagnosed her with DAH due to an anti-GBM disease. After corticosteroid pulse therapy, plasma exchange was performed five times; her oxygen saturation and chest radiologic findings improved gradually. Following five cycles of plasma exchange, her oxygen saturation recovered to 95% in room air.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>To our knowledge, this is the first reported case of vasculitis caused by MPA and anti-GBM disease leading to the development of AKI and DAH during treatment of SCLC. SCLC, MPA, and anti-GBM disease may occur sequentially. A double-positive disease might have a worse prognosis; therefore, intensive therapy is more likely to achieve a better outcome.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-020-02614-3","type":"journal-article","created":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:03:43Z","timestamp":1612137823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sequential occurrence of microscopic polyangiitis and anti-glomerular basement membrane disease in a patient with small cell lung cancer: a case report"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3890-7882","authenticated-orcid":false,"given":"Yusuke","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Sakuragi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayano","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Kakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michihiro","family":"Uyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Marumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motonari","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,1]]},"reference":[{"key":"2614_CR1","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1136\/bmj.e26","volume":"344","author":"A Berden","year":"2012","unstructured":"Berden A, G\u00f6\u00e7eroglu A, Jayne D, Luqmani R, Rasmussen N, Bruijn JA, et al. Diagnosis and management of ANCA associated vasculitis. BMJ. 2012;344:e26.","journal-title":"BMJ"},{"key":"2614_CR2","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.2215\/CJN.01380217","volume":"12","author":"SP McAdoo","year":"2017","unstructured":"McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017;12:1162\u201372.","journal-title":"Clin J Am Soc Nephrol."},{"key":"2614_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1056\/NEJMoa0910500","volume":"363","author":"V Pedchenko","year":"2010","unstructured":"Pedchenko V, Bondar O, Fogo AB, Vanacore R, Voziyan P, Kitching AR, et al. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010;363:343\u201354.","journal-title":"N Engl J Med."},{"key":"2614_CR4","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/0272-6386(95)90489-1","volume":"26","author":"AK Short","year":"1995","unstructured":"Short AK, Esnault VL, Lockwood CM. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995;26:439\u201345.","journal-title":"Am J Kidney Dis."},{"key":"2614_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.kint.2017.03.014","volume":"92","author":"SP McAdoo","year":"2017","unstructured":"McAdoo SP, Tanna A, Hru\u0161kov\u00e1 Z, Holm L, Weiner M, Arulkumaran N, et al. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int. 2017;92:693\u2013702.","journal-title":"Kidney Int."},{"key":"2614_CR6","doi-asserted-by":"publisher","first-page":"e0126016","DOI":"10.1371\/journal.pone.0126016","volume":"10","author":"W Shang","year":"2015","unstructured":"Shang W, Ning Y, Xu X, Li M, Guo S, Han M, et al. Incidence of cancer in ANCA-associated vasculitis: a meta-analysis of observational studies. PLoS ONE. 2015;10:e0126016.","journal-title":"PLoS ONE"},{"key":"2614_CR7","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/art.40538","volume":"70","author":"H Watanabe","year":"2018","unstructured":"Watanabe H, Sada KE, Matsumoto Y, Harigai M, Amano K, Dobashi H, et al. Association between reappearance of myeloperoxidase-antineutrophil cytoplasmic antibody and relapse in antineutrophil cytoplasmic antibody-associated vasculitis: subgroup analysis of nationwide prospective cohort studies. Arthritis Rheumatol. 2018;70:1626\u201333.","journal-title":"Arthritis Rheumatol."},{"key":"2614_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/00005792-198507000-00003","volume":"64","author":"JP Johnson","year":"1985","unstructured":"Johnson JP, Moore J, Austin HA, Balow JE, Antonovych TT, Wilson CB. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore). 1985;64:219\u201327.","journal-title":"Medicine (Baltimore)."},{"key":"2614_CR9","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/j.1523-1755.2004.00917.x","volume":"66","author":"JB Levy","year":"2004","unstructured":"Levy JB, Hammad T, Coulthart A, Dougan T, Pusey CD. Clinical features and outcome of patients with both ANCA and anti-GBM antibodies. Kidney Int. 2004;66:1535\u201340.","journal-title":"Kidney Int."},{"key":"2614_CR10","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1681\/ASN.2010090928","volume":"22","author":"SW Olson","year":"2011","unstructured":"Olson SW, Arbogast CB, Baker TP, Owshalimpur D, Oliver DK, Abbott KC, et al. Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease. J Am Soc Nephrol. 2011;22:1946\u201352.","journal-title":"J Am Soc Nephrol."},{"key":"2614_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1093\/omcr\/omw026","volume":"2016","author":"PS Chan","year":"2016","unstructured":"Chan PS, Leung MH. Sequential occurrence of anti-glomerular basement membrane disease 9 years after anti-neutrophil cytoplasmic antibody-associated vasculitis. Oxf Med Case Reports. 2016;2016:91\u20133.","journal-title":"Oxf Med Case Reports."},{"key":"2614_CR12","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1053\/j.ajkd.2009.04.026","volume":"54","author":"S Clyne","year":"2009","unstructured":"Clyne S, Frederick C, Arndt F, Lewis J, Fogo AB. Concurrent and discrete clinicopathological presentations of Wegener granulomatosis and anti-glomerular basement membrane disease. Am J Kidney Dis. 2009;54:1116\u201320.","journal-title":"Am J Kidney Dis."},{"key":"2614_CR13","first-page":"1695","volume":"149","author":"P Heeringa","year":"1996","unstructured":"Heeringa P, Brouwer E, Klok PA, Huitema MG, van den Born J, Weening JJ, et al. Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat. Am J Pathol. 1996;149:1695\u2013706.","journal-title":"Am J Pathol."},{"key":"2614_CR14","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S0272-6386(99)70366-5","volume":"34","author":"CA Verburgh","year":"1999","unstructured":"Verburgh CA, Bruijn JA, Daha MR, van Es LA. Sequential development of anti-GBM nephritis and ANCA-associated Pauci-immune glomerulonephritis. Am J Kidney Dis. 1999;34:344\u20138.","journal-title":"Am J Kidney Dis."},{"key":"2614_CR15","first-page":"242","volume":"25","author":"K Uto","year":"2018","unstructured":"Uto K, Yanagi S, Tsubouchi H, Matsumoto N, Nakazato M. Successful treatment of steroid-refractory double-positive ANCA and anti-GBM disease with a combination of plasma exchange and immunosuppression: a case report and literature review. Respir Med Case Rep. 2018;25:242\u20136.","journal-title":"Respir Med Case Rep."},{"key":"2614_CR16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3899\/jrheum.160885","volume":"44","author":"EE van Daalen","year":"2017","unstructured":"van Daalen EE, Rahmattulla C, Wolterbeek R, Bruijn JA, Bajema IM. Incidence of malignancy prior to antineutrophil cytoplasmic antibody-associated vasculitis compared to the general population. J Rheumatol. 2017;44:314\u20138.","journal-title":"J Rheumatol."},{"key":"2614_CR17","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1093\/rheumatology\/keh374","volume":"43","author":"T Pankhurst","year":"2004","unstructured":"Pankhurst T, Savage CO, Gordon C, Harper L. Malignancy is increased in ANCA-associated vasculitis. Rheumatology (Oxford). 2004;43:1532\u20135.","journal-title":"Rheumatology (Oxford)"},{"key":"2614_CR18","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.3899\/jrheum.181438","volume":"47","author":"C Heijl","year":"2020","unstructured":"Heijl C, Westman K, H\u00f6glund P, Mohammad AJ. Malignancies in patients with antineutrophil cytoplasmic antibody-associated vasculitis: a Population-based Cohort Study. J Rheumatol. 2020;47:1229\u201337.","journal-title":"J Rheumatol."},{"key":"2614_CR19","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1529-8019.2010.01367.x","volume":"23","author":"G Buggiani","year":"2010","unstructured":"Buggiani G, Krysenka A, Grazzini M, Va\u0161k\u016f V, Hercogov\u00e1 J, Lotti T. Paraneoplastic vasculitis and paraneoplastic vascular syndromes. Dermatol Ther. 2010;23:597\u2013605.","journal-title":"Dermatol Ther."},{"key":"2614_CR20","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5306\/wjco.v5.i3.197","volume":"5","author":"N Kanaji","year":"2014","unstructured":"Kanaji N, Watanabe N, Kita N, Bandoh S, Tadokoro A, Ishii T, et al. Paraneoplastic syndromes associated with lung cancer. World J Clin Oncol. 2014;5:197\u2013223.","journal-title":"World J Clin Oncol."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02614-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-020-02614-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-020-02614-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:04:03Z","timestamp":1612137843000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-020-02614-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2614"],"URL":"https:\/\/doi.org\/10.1186\/s13256-020-02614-3","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,1]]},"assertion":[{"value":"2 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This case report was approved by the Ethics Committee of Kitano Hospital.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication could not be obtained despite all reasonable attempts at contacting our deceased patient\u2019s next of kin. Every effort has been made to protect the identity of our patient and there is no reason to believe that our patient would have objected to publication. The institutional review board approved this work and its publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}